Global Market Study on Biobetters: Lower Dosage Frequency to drive market expansion
Biobetters Market Analysis 2022 - 2029
A recent market study published by Persistence Market Research (PMR) on the Biobetters Market including global industry analysis for 2014-2021 & opportunity assessment for 2022 - 2029, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the market, growth prospects are obtained with utmost precision.
Biobetters Market: Segmentation
The global Biobetters Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Molecule Type
G-CSF Biobetters
Insulin Biobetters
Erythropoietin Biobetters
Monoclonal Antibodies Biobetters
Others
Disease Indication
Cancer
Diabetes
Genetic disease
Neurological Disorders
Others
Region
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa (MEA)
Key Questions Answered in Report
The research study offers inclusive insights about the growth of the market in the most comprehensive manner. Key insights offered in the report answer some of the most salient questions that assist stakeholders in gauging all the emerging possibilities.
What are the key trends that are constantly shaping market growth?
Which are the prominent regions that offer plentiful opportunities for players in the market?
How has the outbreak of COVID-19 affected the market and what would the trend be like during the forecast period?
What are the differential strategies adopted by key players to hold a significant share in the Biobetters market?
Research Methodology
A unique and promising research methodology forms the base of the market report for the forecast period. This report has been prepared after comprehensive analysis of market events, and riveting insights have been compiled meticulously.
The research methodology is a two-step process comprising primary and secondary research. Key stakeholders, including suppliers, service providers, and experts of several designations, including executive vice presidents, directors, technical advisors, GM marketing professionals, and sales professionals have been interviewed. Secondary sources referred to obtain information include investor presentations of manufacturers, World Bank, IMF, and other credible sources.
The research report includes a competitive landscape that provides a dashboard view of the key competitors operating in the market. Some of the market players included in this section are F.Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, SERVIER, Porton Biopharma Limited, Eli Lily and Company, Novo Nordisk A/S, Biogen Inc., CSL Behring GmbH, and Teva Pharmaceutical Industries Ltd., among others.
- 1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Market Analysis
- 1.3. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Key Market Trends
- 3.1. Key Trends Impacting the Market
- 3.2. Product Innovation / Development Trends
- 4. Key Success Factors
- 4.1. Recent Product Launches
- 4.2. Promotional Strategies, by Manufacturers
- 4.3. Regulatory Scenario
- 5. Global Biobetters Market Demand (in Value or Size in US$ Mn) Analysis 2014-2021 and Forecast, 2022-2029
- 5.1. Historical Market Value (US$ Mn) Analysis, 2014-2021
- 5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029
- 5.2.1. Y-o-Y Growth Trend Analysis
- 5.2.2. Absolute $ Opportunity Analysis
- 6. Market Background
- 6.1. Macro-Economic Factors
- 6.1.1. Global Healthcare Spending Outlook
- 6.1.2. Global Pharmaceutical Outlook
- 6.1.3. Regional Healthcare Market Outlook
- 6.2. Forecast Factors - Relevance & Impact
- 6.2.1. Innovation of New Products
- 6.2.2. Increasing Research & Developmental Activities
- 6.2.3. Increasing Number of Biotechnology Industries And Research Institutes
- 6.2.4. Adoption of New Technologies In Research Field
- 6.3. Market Dynamics
- 6.3.1. Drivers
- 6.3.2. Restraints
- 6.3.3. Opportunity Analysis
- 7. Global Biobetters Market Analysis 2014-2021 and Forecast 2022-2029, by Product Type
- 7.1. Introduction / Key Findings
- 7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 - 2021
- 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2022 - 2029
- 7.3.1. Erythropoietin Biobetters
- 7.3.2. G-CSF Biobetters
- 7.3.3. Interferon Biobetters
- 7.3.4. Insulin Biobetters
- 7.3.5. Monoclonal Antibodies Biobetters
- 7.3.6. Anti-haemophilic Factor
- 7.3.7. Others
- 7.4. Market Attractiveness Analysis By Product Type
- 8. Global Biobetters Market Analysis 2014-2021 and Forecast 2022-2029, By Indication
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014 - 2021
- 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2022 - 2029
- 8.3.1. Diabetes
- 8.3.2. Cancer
- 8.3.3. Renal Disease
- 8.3.4. Neurodegenerative Disease
- 8.3.5. Genetic Disorders (Haemophilia)
- 8.3.6. Others
- 8.4. Market Attractiveness Analysis By Indication
- 9. Global Biobetters Market Analysis 2014-2021 and Forecast 2022-2029, By Route of Administration
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2014 - 2021
- 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022 - 2029
- 9.3.1. Subcutaneous
- 9.3.2. Intravenous
- 9.4. Market Attractiveness Analysis By Route of Administration
- 10. Global Biobetters Market Analysis 2014-2021 and Forecast 2022-2029, By Distribution Channel
- 10.1. Introduction / Key Findings
- 10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014 - 2021
- 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2029
- 10.3.1. Hospital Pharmacies
- 10.3.2. Retail Pharmacies
- 10.3.3. Online Pharmacies
- 10.4. Market Attractiveness Analysis By Distribution Channel
- 11. Global Biobetters Market Analysis 2014-2021 and Forecast 2022-2029, by Region
- 11.1. Introduction
- 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2021
- 11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2029
- 11.3.1. North America
- 11.3.2. Latin America
- 11.3.3. Europe
- 11.3.4. East Asia
- 11.3.5. South Asia
- 11.3.6. Oceania
- 11.3.7. MEA
- 11.4. Market Attractiveness Analysis By Region
- 12. North America Biobetters Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029
- 12.1. Introduction
- 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021
- 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029
- 12.3.1. By Country
- 12.3.1.1. U.S.
- 12.3.1.2. Canada
- 12.3.2. By Product Type
- 12.3.3. By Indication
- 12.3.4. By Route of Administration
- 12.3.5. By Distribution Channel
- 12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Product Type
- 12.4.3. By Indication
- 12.4.4. By Route of Administration
- 12.4.5. By Distribution Channel
- 12.5. Key Market Participants - Intensity Mapping
- 12.6. Drivers and Restraints - Impact Analysis
- 13. Latin America Biobetters Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029
- 13.1. Introduction
- 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021
- 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029
- 13.3.1. By Country
- 13.3.1.1. Brazil
- 13.3.1.2. Mexico
- 13.3.1.3. Rest of Latin America
- 13.3.2. By Product Type
- 13.3.3. By Indication
- 13.3.4. By Route of Administration
- 13.3.5. By Distribution Channel
- 13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Product Type
- 13.4.3. By Indication
- 13.4.4. By Route of Administration
- 13.4.5. By Distribution Channel
- 13.5. Key Market Participants - Intensity Mapping
- 13.6. Drivers and Restraints - Impact Analysis
- 14. Europe Biobetters Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029
- 14.1. Introduction
- 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021
- 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029
- 14.3.1. By Country
- 14.3.1.1. Germany
- 14.3.1.2. Italy
- 14.3.1.3. France
- 14.3.1.4. U.K.
- 14.3.1.5. Spain
- 14.3.1.6. BENELUX
- 14.3.1.7. Russia
- 14.3.1.8. Rest of Europe
- 14.3.2. By Product Type
- 14.3.3. By Indication
- 14.3.4. By Route of Administration
- 14.3.5. By Distribution Channel
- 14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product Type
- 14.4.3. By Indication
- 14.4.4. By Route of Administration
- 14.4.5. By Distribution Channel
- 14.5. Key Market Participants - Intensity Mapping
- 14.6. Drivers and Restraints - Impact Analysis
- 15. South Asia Biobetters Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029
- 15.1. Introduction
- 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021
- 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029
- 15.3.1. By Country
- 15.3.1.1. India
- 15.3.1.2. Thailand
- 15.3.1.3. Indonesia
- 15.3.1.4. Malaysia
- 15.3.1.5. Rest of South Asia
- 15.3.2. By Product Type
- 15.3.3. By Indication
- 15.3.4. By Route of Administration
- 15.3.5. By Distribution Channel
- 15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Product Type
- 15.4.3. By Indication
- 15.4.4. By Route of Administration
- 15.4.5. By Distribution Channel
- 15.5. Key Market Participants - Intensity Mapping
- 15.6. Drivers and Restraints - Impact Analysis
- 16. East Asia Biobetters Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029
- 16.1. Introduction
- 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021
- 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029
- 16.3.1. By Country
- 16.3.1.1. China
- 16.3.1.2. Japan
- 16.3.1.3. South Korea
- 16.3.2. By Product Type
- 16.3.3. By Indication
- 16.3.4. By Route of Administration
- 16.3.5. By Distribution Channel
- 16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product Type
- 16.4.3. By Indication
- 16.4.4. By Route of Administration
- 16.4.5. By Distribution Channel
- 16.5. Key Market Participants - Intensity Mapping
- 16.6. Drivers and Restraints - Impact Analysis
- 17. Oceania Biobetters Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029
- 17.1. Introduction
- 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021
- 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029
- 17.3.1. By Country
- 17.3.1.1. Australia
- 17.3.1.2. New Zealand
- 17.3.2. By Product Type
- 17.3.3. By Indication
- 17.3.4. By Route of Administration
- 17.3.5. By Distribution Channel
- 17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product Type
- 17.4.3. By Indication
- 17.4.4. By Route of Administration
- 17.4.5. By Distribution Channel
- 17.5. Key Market Participants - Intensity Mapping
- 17.6. Drivers and Restraints - Impact Analysis
- 18. Middle East and Africa Biobetters Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029
- 18.1. Introduction
- 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021
- 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029
- 18.3.1. By Country
- 18.3.1.1. GCC Countries
- 18.3.1.2. Turkey
- 18.3.1.3. Northern Africa
- 18.3.1.4. South Africa
- 18.3.1.5. Rest of Middle East and Africa
- 18.3.2. By Product Type
- 18.3.3. By Indication
- 18.3.4. By Route of Administration
- 18.3.5. By Distribution Channel
- 18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Product Type
- 18.4.3. By Indication
- 18.4.4. By Route of Administration
- 18.4.5. By Distribution Channel
- 18.5. Key Market Participants - Intensity Mapping
- 18.6. Drivers and Restraints - Impact Analysis
- 19. Market Structure Analysis
- 19.1. Market Analysis by Tier of Companies
- 19.2. Market Share Analysis of Top Players
- 19.3. Market Presence Analysis
- 19.3.1. By Regional footprint of Players
- 19.3.2. Product foot print by Players
- 19.3.3. Channel Foot Print by Players
- 20. Competition Analysis
- 20.1. Competition Dashboard
- 20.2. Competition Benchmarking
- 20.3. Competition Deep Dive
- 20.3.1. Amgen Inc.
- 20.3.1.1. Overview
- 20.3.1.2. Product Portfolio
- 20.3.1.3. Profitability by Market Segments (Product/Channel/Region)
- 20.3.1.4. Sales Footprint
- 20.3.1.5. Strategy Overview
- 20.3.1.5.1. Marketing Strategy
- 20.3.1.5.2. Product Strategy
- 20.3.1.5.3. Channel Strategy
- 20.3.2. F. Hoffmann-La Roche AG
- 20.3.2.1. Overview
- 20.3.2.2. Product Portfolio
- 20.3.2.3. Profitability by Market Segments (Product/Channel/Region)
- 20.3.2.4. Sales Footprint
- 20.3.2.5. Strategy Overview
- 20.3.2.5.1. Marketing Strategy
- 20.3.2.5.2. Product Strategy
- 20.3.2.5.3. Channel Strategy
- 20.3.3. Merck & Co. Inc.
- 20.3.3.1. Overview
- 20.3.3.2. Product Portfolio
- 20.3.3.3. Profitability by Market Segments (Product/Channel/Region)
- 20.3.3.4. Sales Footprint
- 20.3.3.5. Strategy Overview
- 20.3.3.5.1. Marketing Strategy
- 20.3.3.5.2. Product Strategy
- 20.3.3.5.3. Channel Strategy
- 20.3.4. Sanofi SA
- 20.3.4.1. Overview
- 20.3.4.2. Product Portfolio
- 20.3.4.3. Profitability by Market Segments (Product/Channel/Region)
- 20.3.4.4. Sales Footprint
- 20.3.4.5. Strategy Overview
- 20.3.4.5.1. Marketing Strategy
- 20.3.4.5.2. Product Strategy
- 20.3.4.5.3. Channel Strategy
- 20.3.5. SERVIER
- 20.3.5.1. Overview
- 20.3.5.2. Product Portfolio
- 20.3.5.3. Profitability by Market Segments (Product/Channel/Region)
- 20.3.5.4. Sales Footprint
- 20.3.5.5. Strategy Overview
- 20.3.5.5.1. Marketing Strategy
- 20.3.5.5.2. Product Strategy
- 20.3.5.5.3. Channel Strategy
- 20.3.6. Porton Biopharma Limited
- 20.3.6.1. Overview
- 20.3.6.2. Product Portfolio
- 20.3.6.3. Profitability by Market Segments (Product/Channel/Region)
- 20.3.6.4. Sales Footprint
- 20.3.6.5. Strategy Overview
- 20.3.6.5.1. Marketing Strategy
- 20.3.6.5.2. Product Strategy
- 20.3.6.5.3. Channel Strategy
- 20.3.7. Eli Lily and Company
- 20.3.7.1. Overview
- 20.3.7.2. Product Portfolio
- 20.3.7.3. Profitability by Market Segments (Product/Channel/Region)
- 20.3.7.4. Sales Footprint
- 20.3.7.5. Strategy Overview
- 20.3.7.5.1. Marketing Strategy
- 20.3.7.5.2. Product Strategy
- 20.3.7.5.3. Channel Strategy
- 20.3.8. Novo Nordisk A/S
- 20.3.8.1. Overview
- 20.3.8.2. Product Portfolio
- 20.3.8.3. Profitability by Market Segments (Product/Channel/Region)
- 20.3.8.4. Sales Footprint
- 20.3.8.5. Strategy Overview
- 20.3.8.5.1. Marketing Strategy
- 20.3.8.5.2. Product Strategy
- 20.3.8.5.3. Channel Strategy
- 20.3.9. Biogen Inc.
- 20.3.9.1. Overview
- 20.3.9.2. Product Portfolio
- 20.3.9.3. Profitability by Market Segments (Product/Channel/Region)
- 20.3.9.4. Sales Footprint
- 20.3.9.5. Strategy Overview
- 20.3.9.5.1. Marketing Strategy
- 20.3.9.5.2. Product Strategy
- 20.3.9.5.3. Channel Strategy
- 20.3.10. CSL Behring GmbH
- 20.3.10.1. Overview
- 20.3.10.2. Product Portfolio
- 20.3.10.3. Profitability by Market Segments (Product/Channel/Region)
- 20.3.10.4. Sales Footprint
- 20.3.10.5. Strategy Overview
- 20.3.10.5.1. Marketing Strategy
- 20.3.10.5.2. Product Strategy
- 20.3.10.5.3. Channel Strategy
- 20.3.11. Teva Pharmaceutical Industries Ltd.
- 20.3.11.1. Overview
- 20.3.11.2. Product Portfolio
- 20.3.11.3. Profitability by Market Segments (Product/Channel/Region)
- 20.3.11.4. Sales Footprint
- 20.3.11.5. Strategy Overview
- 20.3.11.5.1. Marketing Strategy
- 20.3.11.5.2. Product Strategy
- 20.3.11.5.3. Channel Strategy
- 21. Assumptions and Acronyms Used
- 22. Research Methodology
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook